Search for data related to genes or regions
+
28 Study Datasets reported containing markers in gene or region CDH13 (no 5′ and no 3′ flanks) with -log p ≥ 3
No data sets (in No Phenotypes) added to Browser
Phenotype tested in Study Phenotype ontology annotation Total p-values in Study StudyAdd data sets to Browser Related Study data
4 kHz hearing threshold (HGVPM567)
  • Hearing
959,443 GWAS of 4 kHz hearing threshold in a British population (HGVST311)
Alzheimer's disease (HGVPM576)
  • Alzheimer Disease
1,711 GWAS of Alzheimer's disease (HGVST318)
Amyotrophic lateral sclerosis (HGVPM114)
  • Amyotrophic Lateral Sclerosis
350 GWAS of amyotrophic lateral sclerosis (HGVST76)
Attention deficit hyperactivity disorder (HGVPM215)
  • Attention Deficit Disorder with Hyperactivity
26 GWAS of attention deficit hyperactivity disorder (HGVST165)
Bipolar disorder (HGVPM1513)
  • Bipolar Disorder
809,854 Whole Genome Association Study of bipolar disorder (HGVST889)
Bipolar disorder (HGVPM837)
  • Bipolar Disorder
1,509,315 GWAS of bipolar disorder in European American and African American individuals (HGVST472)
Birth weight (HGVPM571)
  • Birth Weight
959,443 GWAS of birth weight in a British population (HGVST315)
Body mass index (HGVPM1111)
  • Body Mass Index
2,471,541 GWAS of body mass index (HGVST640)
Crohn's disease (HGVPM1169)
  • Crohn Disease
953,239 GWAS of Crohn's disease (HGVST680)
Diabetic nephropathy in type I diabetes (HGVPM1524)
  • Diabetic Nephropathies
358,475 Genetics of kidneys in diabetes (GoKinD) (HGVST890)
FEV1/FVC (HGVPM918)
  • Forced Expiratory Volume
3,000 GWAS of lung function (HGVST513)
Height-adjusted highest forced expiratory volume (HGVPM566)
  • Forced Expiratory Volume
959,443 GWAS of height-adjusted highest forced expiratory volume in a British population (HGVST310)
Log10 fibrinogen (HGVPM570)
  • Fibrinogen
959,443 GWAS of log10 fibrinogen in a British population (HGVST314)
Narcolepsy (HGVPM165)
  • Narcolepsy
1,223,685 GWAS of narcolepsy in a Japanese population (HGVST115)
Parkinson's disease (HGVPM3)
  • Parkinson Disease
1,187,523 GWAS of Parkinson's disease (HGVST6)
Partial epilepsies (HGVPM929)
  • Epilepsies, Partial
1,056,072 GWAS of partial epilepsies (HGVST522)
Prostate cancer (HGVPM1)
  • Prostatic Neoplasms
4,170,229 GWAS of prostate cancer (HGVST1)
Prostate cancer (HGVPM43)
  • Prostatic Neoplasms
59 GWAS of breast cancer and prostate cancer in the Framingham Heart Study (HGVST32)
Prostate cancer (HGVPM915)
  • Prostatic Neoplasms
372 GWAS of prostate cancer (HGVST512)
Psoriasis (HGVPM1532)
  • Psoriasis
440,151 GWAS of psoriasis (HGVST902)
Rheumatoid arthritis (HGVPM1226)
  • Arthritis, Rheumatoid
4,948 GWAS of rheumatoid arthritis in Koreans (HGVST710)
Rheumatoid arthritis (HGVPM235)
  • Arthritis, Rheumatoid
899,216 GWAS of rheumatoid arthritis in the Spanish population (HGVST185)
Schizophrenia (HGVPM1533)
  • Schizophrenia
1,510,341 GWAS of schizophrenia (HGVST903)
Schizophrenia (HGVPM589)
  • Schizophrenia
3,295 GWAS of schizophrenia (HGVST320)
Spatial working memory strategy (HGVPM851)
  • Neuropsychological Tests
99 GWAS of cognitive performance (HGVST481)
Type I diabetes (HGVPM149)
  • Diabetes Mellitus, Type 1
629 GWAS and meta-analysis of type I diabetes mellitus (HGVST103)
Type II diabetes (HGVPM5)
  • Diabetes Mellitus, Type 2
772,550 GWAS of type II diabetes mellitus (HGVST3)
Ulcerative colitis (HGVPM1256)
  • Colitis, Ulcerative
1,428,497 GWAS of ulcerative colitis (HGVST730)